Literature DB >> 26046715

Hypnotherapy for Esophageal Disorders.

Megan E Riehl1, Laurie Keefer.   

Abstract

Hypnotherapy is an evidence based intervention for the treatment of functional bowel disorders, particularly irritable bowel syndrome. While similar in pathophysiology, less is known about the utility of hypnotherapy in the upper gastrointestinal tract. Esophageal disorders, most of which are functional in nature, cause painful and uncomfortable symptoms that impact patient quality of life and are difficult to treat from a medical perspective. After a thorough medical workup and a failed trial of proton pump inhibitor therapy, options for treatment are significantly limited. While the pathophysiology is likely multifactorial, two critical factors are believed to drive esophageal symptoms--visceral hypersensitivity and symptom hypervigilance. The goal of esophageal directed hypnotherapy is to promote a deep state of relaxation with focused attention allowing the patient to learn to modulate physiological sensations and symptoms that are not easily addressed with conventional medical intervention. Currently, the use of hypnosis is suitable for dysphagia, globus, functional chest pain/non-cardiac chest pain, dyspepsia, and functional heartburn. In this article the authors will provide a rationale for the use of hypnosis in these disorders, presenting the science whenever available, describing their approach with these patients, and sharing a case study representing a successful outcome.

Entities:  

Keywords:  behavioral medicine; esophageal disorders; gastroesophageal reflux disease; heartburn; hypnosis

Mesh:

Substances:

Year:  2015        PMID: 26046715      PMCID: PMC4482465          DOI: 10.1080/00029157.2015.1025355

Source DB:  PubMed          Journal:  Am J Clin Hypn        ISSN: 0002-9157


  41 in total

Review 1.  The growing case for hypnosis as adjunctive therapy for functional gastrointestinal disorders.

Authors:  Olafur S Palsson; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

2.  Prokinetic effect of gut-oriented hypnosis on gastric emptying.

Authors:  G Chiarioni; I Vantini; F De Iorio; L Benini
Journal:  Aliment Pharmacol Ther       Date:  2006-04-15       Impact factor: 8.171

3.  Hypnotherapy treatment for dysphagia.

Authors:  K F Kopel; M Quinn
Journal:  Int J Clin Exp Hypn       Date:  1996-04

4.  Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness.

Authors:  Wendy M Gonsalkorale; Lesley A Houghton; Peter J Whorwell
Journal:  Am J Gastroenterol       Date:  2002-04       Impact factor: 10.864

5.  Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study.

Authors:  Nikos Viazis; Anastasia Keyoglou; Alexandros K Kanellopoulos; George Karamanolis; John Vlachogiannakos; Konstantinos Triantafyllou; Spiros D Ladas; Dimitrios G Karamanolis
Journal:  Am J Gastroenterol       Date:  2011-05-31       Impact factor: 10.864

6.  Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial.

Authors:  R E Clouse; P J Lustman; T C Eckert; D M Ferney; L S Griffith
Journal:  Gastroenterology       Date:  1987-04       Impact factor: 22.682

7.  Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: a preliminary model.

Authors:  I C Scarinci; J McDonald-Haile; L A Bradley; J E Richter
Journal:  Am J Med       Date:  1994-08       Impact factor: 4.965

8.  Multicenter study of gastroenterologists' ability to identify anxiety and depression in a new patient encounter and its impact on diagnosis.

Authors:  Laurie Keefer; Gregory Sayuk; Jason Bratten; Robert Rahimi; Michael P Jones
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

Review 9.  Functional esophageal disorders: a review of diagnosis and management.

Authors:  Anand R Kumar; Philip O Katz
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-07       Impact factor: 3.869

Review 10.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  A C Ford; N J Talley; P S Schoenfeld; E M M Quigley; P Moayyedi
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059

View more
  11 in total

Review 1.  The Proton Pump Inhibitor Nonresponder: a Behavioral Approach to Improvement and Wellness.

Authors:  Megan E Riehl; Joan W Chen
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

2.  Internalized Stigma in Patients with Eosinophilic Gastrointestinal Disorders.

Authors:  L Guadagnoli; T H Taft
Journal:  J Clin Psychol Med Settings       Date:  2020-03

3.  Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease.

Authors:  T H Taft; J R Triggs; D A Carlson; L Guadagnoli; K N Tomasino; L Keefer; J E Pandolfino
Journal:  Aliment Pharmacol Ther       Date:  2018-03-12       Impact factor: 8.171

Review 4.  Psychological Considerations and Interventions in Inflammatory Bowel Disease Patient Care.

Authors:  Tiffany H Taft; Sarah Ballou; Alyse Bedell; Devin Lincenberg
Journal:  Gastroenterol Clin North Am       Date:  2017-10-03       Impact factor: 3.806

Review 5.  How to Diagnose and Treat Functional Chest Pain.

Authors:  Jose M Remes-Troche
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

Review 6.  Brain-Gut Therapies for Pediatric Functional Gastrointestinal Disorders and Inflammatory Bowel Disease.

Authors:  Hannibal Person; Laurie Keefer
Journal:  Curr Gastroenterol Rep       Date:  2019-03-12

Review 7.  An update on current treatment strategies for laryngopharyngeal reflux symptoms.

Authors:  Amanda J Krause; Erin H Walsh; Philip A Weissbrod; Tiffany H Taft; Rena Yadlapati
Journal:  Ann N Y Acad Sci       Date:  2021-12-17       Impact factor: 6.499

Review 8.  Patients with refractory reflux symptoms: What do they have and how should they be managed?

Authors:  P J Kahrilas; L Keefer; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2015-09       Impact factor: 3.598

9.  Low-Dose Tricyclics for Esophageal Hypersensitivity: Is it all Placebo Effect?

Authors:  Laurie Keefer; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2016-02       Impact factor: 10.864

10.  Esophageal hypervigilance is prevalent across gastroesophageal reflux disease presentations.

Authors:  Livia Guadagnoli; Rena Yadlapati; Tiffany Taft; John E Pandolfino; Michael Tye; Laurie Keefer
Journal:  Neurogastroenterol Motil       Date:  2021-01-11       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.